Page last updated: 2024-10-19

phenol and Acute Relapsing Multiple Sclerosis

phenol has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
" We previously reported that relapsing remitting multiple sclerosis patients treated with dimethyl fumarate have a prominent depletion of the gut microbiota, thereby suggesting that studying the composition of plasma and CSF samples from these patients may help to identify microbially derived metabolites."4.12Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma. ( Amatruda, M; Button, J; Casaccia, P; Edwards, K; Frazier, C; Inbar, B; Kiebish, MA; Kim-Schulze, S; Lublin, F; Ntranos, A; Park, HJ; Tolstikov, V; Wentling, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ntranos, A1
Park, HJ1
Wentling, M1
Tolstikov, V1
Amatruda, M1
Inbar, B1
Kim-Schulze, S1
Frazier, C1
Button, J1
Kiebish, MA1
Lublin, F1
Edwards, K1
Casaccia, P1

Other Studies

1 other study available for phenol and Acute Relapsing Multiple Sclerosis

ArticleYear
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
    Brain : a journal of neurology, 2022, 04-18, Volume: 145, Issue:2

    Topics: Animals; Biomarkers; Dimethyl Fumarate; Humans; Indican; Multiple Sclerosis; Multiple Sclerosis, Rel

2022